| |
| |
|
| Insider
Information: |
Macdonald Guy |
| Relationship: |
|
| City: |
Cambridge |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
42,000 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$62,080 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
42,000 |
|
|
| Total
Value |
$62,080 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
1
|
0
|
|
Stock
price went up :
|
1
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
1.0
|
0.0
|
| Percentage
Gain/Loss : |
 9.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Idenix Pharmaceuticals Inc |
IDIX |
Executive VP, Operations |
2004-07-27 |
10,000 |
2004-07-27 |
0 |
Premium* |
|
|
Tetraphase Pharmaceuticals Inc |
TTPH |
Director |
2020-07-28 |
0 |
2014-02-10 |
0 |
Premium* |
|
|
Scynexis Inc |
SCYX |
|
2023-06-15 |
32,000 |
2016-06-24 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
53 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 3
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| TTPH |
Tetraphase Pharmaceutical... |
President and Chief Executive |
• • – |
2014-02-10 |
4 |
AS |
$14.42 |
$216,300 |
D/D |
(15,000) |
0 |
0 |
- |
|
| TTPH |
Tetraphase Pharmaceutical... |
President and Chief Executive |
• • – |
2014-04-14 |
4 |
AS |
$9.69 |
$145,350 |
D/D |
(15,000) |
0 |
0 |
- |
|
| TTPH |
Tetraphase Pharmaceutical... |
President and Chief Executive |
• • – |
2014-05-19 |
4 |
AS |
$9.00 |
$135,000 |
D/D |
(15,000) |
0 |
0 |
- |
|
| TTPH |
Tetraphase Pharmaceutical... |
President and Chief Executive |
• • – |
2014-06-17 |
4 |
AS |
$12.28 |
$184,226 |
D/D |
(15,000) |
0 |
0 |
- |
|
| TTPH |
Tetraphase Pharmaceutical... |
Director |
– • – |
2020-07-28 |
4 |
D |
$0.00 |
$0 |
D/D |
(15,703) |
0 |
0 |
- |
|
| TTPH |
Tetraphase Pharmaceutical... |
Director |
– • – |
2019-12-06 |
4 |
S |
$2.25 |
$12,903 |
D/D |
(5,735) |
250 |
0 |
- |
|
| TTPH |
Tetraphase Pharmaceutical... |
Director |
– • – |
2019-12-05 |
4 |
S |
$2.34 |
$4,377 |
D/D |
(1,870) |
5,985 |
0 |
- |
|
| IDIX |
Idenix Pharmaceuticals In... |
Executive VP, Operations |
• – – |
2004-07-27 |
4 |
B |
$14.00 |
$140,000 |
D/D |
10,000 |
10,000 |
2.74 |
- |
|
| SCYX |
Scynexis Inc |
Director |
– • – |
2020-12-21 |
4 |
B |
$6.25 |
$50,000 |
D/D |
8,000 |
12,000 |
2.39 |
% |
|
| TTPH |
Tetraphase Pharmaceutical... |
President and Chief Executive |
• • – |
2014-02-10 |
4 |
OE |
$0.87 |
$13,050 |
D/D |
15,000 |
15,000 |
0 |
- |
|
| TTPH |
Tetraphase Pharmaceutical... |
President and Chief Executive |
• • – |
2014-04-14 |
4 |
OE |
$0.87 |
$13,050 |
D/D |
15,000 |
15,000 |
0 |
- |
|
| TTPH |
Tetraphase Pharmaceutical... |
President and Chief Executive |
• • – |
2014-05-19 |
4 |
OE |
$0.87 |
$13,050 |
D/D |
15,000 |
15,000 |
0 |
- |
|
| TTPH |
Tetraphase Pharmaceutical... |
President and Chief Executive |
• • – |
2014-06-17 |
4 |
OE |
$0.87 |
$13,050 |
D/D |
15,000 |
15,000 |
0 |
- |
|
| SCYX |
Scynexis Inc |
Director |
– • – |
2022-06-17 |
4 |
A |
$0.00 |
$0 |
D/D |
10,000 |
22,000 |
0 |
- |
|
| TTPH |
Tetraphase Pharmaceutical... |
President and Chief Executive |
• • – |
2014-07-18 |
4 |
AS |
$10.61 |
$159,102 |
D/D |
(15,000) |
25,000 |
0 |
- |
|
| SCYX |
Scynexis Inc |
|
• • – |
2023-06-15 |
4 |
A |
$0.00 |
$0 |
D/D |
10,000 |
32,000 |
0 |
- |
|
| TTPH |
Tetraphase Pharmaceutical... |
President and Chief Executive |
• • – |
2014-07-18 |
4 |
OE |
$0.87 |
$34,800 |
D/D |
40,000 |
40,000 |
0 |
- |
|
| TTPH |
Tetraphase Pharmaceutical... |
President and Chief Executive |
• • – |
2015-08-06 |
4 |
AS |
$43.65 |
$1,309,500 |
D/D |
(30,000) |
40,000 |
0 |
- |
|
| SCYX |
Scynexis Inc |
Director |
– • – |
2016-06-24 |
4 |
B |
$2.39 |
$95,600 |
D/D |
40,000 |
40,000 |
2.39 |
- |
|
| TTPH |
Tetraphase Pharmaceutical... |
President and Chief Executive |
• • – |
2014-08-05 |
4 |
OE |
$0.87 |
$21,750 |
D/D |
25,000 |
50,000 |
0 |
- |
|
| TTPH |
Tetraphase Pharmaceutical... |
President and Chief Executive |
• • – |
2014-08-20 |
4 |
AS |
$11.59 |
$115,900 |
D/D |
(10,000) |
50,000 |
0 |
- |
|
| TTPH |
Tetraphase Pharmaceutical... |
President and Chief Executive |
• • – |
2014-09-17 |
4 |
AS |
$18.00 |
$180,000 |
D/D |
(10,000) |
50,000 |
0 |
- |
|
| TTPH |
Tetraphase Pharmaceutical... |
President and Chief Executive |
• • – |
2014-09-23 |
4 |
AS |
$18.47 |
$184,660 |
D/D |
(10,000) |
50,000 |
0 |
- |
|
| TTPH |
Tetraphase Pharmaceutical... |
President and Chief Executive |
• • – |
2015-01-20 |
4 |
AS |
$36.59 |
$1,248,972 |
D/D |
(34,135) |
50,000 |
0 |
- |
|
| TTPH |
Tetraphase Pharmaceutical... |
President and Chief Executive |
• • – |
2015-02-02 |
4 |
AS |
$35.09 |
$352,916 |
D/D |
(10,000) |
50,000 |
0 |
- |
|
53 Records found
|
|
Page 1 of 3 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
